Promoter Hypermethylation in Tumor Suppressing Genes p16 and FHIT and Their Relationship with Estrogen Receptor and Progesterone Receptor Status in Breast Cancer Patients from Northern India.

BACKGROUND Aberrant DNA methylation has been recognized in human breast carcinogenesis as a common molecular alteration associated with the loss of expression of a number of key regulatory genes. The present study was undertaken to determine whether methylation and expression of p16 and FHIT genes would correlate with the estrogen receptor (ER) and progesterone receptor (PR) status. METHODS Methylation-specific polymerase chain reaction, messenger RNA (mRNA) expression analysis, immunohistochemistry, and Western blot analysis were performed to study the methylation of p16 and FHIT genes in 351 pairs of malignant/normal breast tissues. We examined the expression of ER and PR in those specimens by immunohistochemistry. Mutations of p16 and FHIT genes in tumors were detected by direct sequencing. RESULTS The frequency of hypermethylation was 31.9% and 36.8% in p16 and FHIT genes, respectively, and showed significant harmony in concordant hypermethylation (P < .0001). In postmenopausal patients, methylation frequency in both genes is significantly higher in poorly and moderately differentiated tumors. Loss of protein expression of p16 and FHIT in 77 and 74 tumors, respectively, is associated with their methylation status in premenopausal women. CONCLUSION We did not find any significant differences in tumor-related gene methylation patterns relevant to both ER and PR status of breast tumors.

• Publication year

  2009

• Venue

  Translational Oncology

• Publication date

  2009-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1593/TLO.09148PMID 19956388PMCID PMC2781065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study

  2009cited by this paper
• Methylation status of p16INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer

  2009cited by this paper
• Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors

  2008cited by this paper
• Estrogen receptor α-negative and progesterone receptor-positive breast cancer: Lab error or real entity?

  2008cited by this paper
• p16 Prevents Centrosome Dysfunction and Genomic Instability in Primary Cells

  2006cited by this paper
• p16INK4a Prevents Centrosome Dysfunction and Genomic Instability in Primary Cells

  2006cited by this paper
• Pattern of expression of genes linked to epigenetic silencing in human breast cancer.

  2006cited by this paper
• DNA methylation profiles of female steroid hormone-driven human malignancies.

  2006cited by this paper
• DNA hypermethylation in breast cancer and its association with clinicopathological features.

  2006cited by this paper
• Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Genetic and Epigenetic Changes in Mammary Epithelial Cells May Mimic Early Events in Carcinogenesis

  2004cited by this paper
• Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen

  2004cited by this paper
• DNA methylation and breast cancer.

  2004cited by this paper
• Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.

  2004cited by this paper
• Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms

  2003cited by this paper
• Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

  2003cited by this paper
• The RB and p53 pathways in cancer.

  2002cited by this paper
• Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.

  2001cited by this paper
• DNA methylation in breast cancer.

  2001cited by this paper
• Loss of Fhit expression is a predictor of poor outcome in tongue cancer.

  2001cited by this paper
• Methylation of the p16(Ink4a) tumor suppressor gene 5'-CpG island in breast cancer.

  2001cited by this paper
• Estimating the world cancer burden: Globocan 2000

  2001cited by this paper
• p16(MTS-1/CDKN2/INK4a) in cancer progression.

  2001cited by this paper
• The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma

  2000cited by this paper
• Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.

  2000cited by this paper
• DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

  2000cited by this paper
• Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.

  1999cited by this paper
• CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer

  1999cited by this paper
• The p16INK4a/CDKN2A tumor suppressor and its relatives.

  1998cited by this paper
• Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and histopathological parameters

  1998cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

  1996cited by this paper
• Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.

  1994cited by this paper
• The Indian Scene

  1955cited by this paper

• Methylation Levels in the Promoter Region of FHIT and PIAS1 Genes Associated with Mastitis Resistance in Xinjiang Brown Cattle

  2023cites this paper
• Epigenetic Silencing of p16INK4a gene in Sporadic Breast Cancer

  2023cites this paper
• A pilot study on DNA hypermethylation status in promoter region of P16 gene in patients with sporadic breast cancer.

  2021cites this paper
• Expressions of FHIT, BCRP and Bcl-2 Proteins in Breast Invasive Ductal Carcinoma

  2019cites this paper
• Investigation of Mutations in Exon 7,8 and Exon 9 of FHIT Gene in Laryngeal Squamous Cell Carcinoma

  2016cites this paper
• DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study

  2016cites this paper
• The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review

  2015cites this paper
• Quantitative detection of methylation of FHIT and BRCA1 promoters in the serum of ductal breast cancer patients

  2015cites this paper
• Analysis of FHIT gene methylation in egyptian breast cancer women: association with clinicopathological features.

  2015influential citation
• Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells

  2015cites this paper
• The clinicopathological significance and drug target potential of FhiT in breast cancer, a meta-analysis and literature review

  2015cites this paper
• The clinicopathological significance and drug target potential of FhiT in breast cancer, a meta-analysis and literature review

  2015cites this paper
• Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.

  2014cites this paper
• Association of mutation and hypermethylation of p21 gene with susceptibility to breast cancer: a study from north India

  2014cites this paper
• Natural Products in Cancer Prevention and Therapy

  2013cites this paper
• Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.

  2013cites this paper
• Low methylation levels of the SFRP1 gene are associated with the basal-like subtype of breast cancer.

  2013cites this paper
• Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.

  2013cites this paper
• Promoter hypermethylation of tumour suppressor genes (p14/ARF and p16/INK4a): case–control study in North Indian population

  2013cites this paper
• Promoter methylation and loss of p16INK4a gene expression in head and neck cancer

  2012cites this paper
• p16 promoter hypermethylation is associated with increased breast cancer risk.

  2012cites this paper
• Cancer Chemoprevention and Nutri-Epigenetics : State of the Art and Future Challenges

  2012cites this paper
• Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashmir.

  2011cites this paper